Dispersal Rate of Radon-219 from Aqueous Radium-223 Solution Containing Sodium Chloride/Citrate-Reference-Cited by-同舟云学术

Dispersal Rate of Radon-219 from Aqueous Radium-223 Solution Containing Sodium Chloride/Citrate

Published:2020 Issue:0 Volume:19 Page:1-9
ISSN:1347-1511
Container-title:Radiation Safety Management
language:en
Short-container-title:Radiat. Saf. Manage.

Author:

NAGATA Kojiro¹,SHIRASAKI Kenji²,TOYOSHIMA Atsushi³⁴,OOE Kazuhiro³⁵,YAMAMURA Tomoo⁴,SHINOHARA Atsushi³⁶⁷,YOSHIMURA Takashi¹⁶

Affiliation:

1. Radioisotope Research Center, Institute for Radiation Sciences, Osaka University

2. Laboratory of Alpha-Ray Emitters, Institute for Materials Research, Tohoku University

3. Division of Science, Institute for Radiation Sciences, Osaka University

4. Institute for Integrated Radiation and Nuclear Science, Kyoto University

5. Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University

6. Project Research Center for Fundamental Sciences, Graduate School of Science, Osaka University

7. Department of Chemistry, Graduate School of Science, Osaka University

Publisher

Japanese Society of Radiation Safety Management

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/rsm/19/0/19_190328/_pdf

Reference20 articles.

1. 1) Vaidyanathan, G., Zalutsky, M. R.: Applications of ²¹¹At and ²²³Ra in Targeted Alpha-Particle Therapy., Curr. Radiopharm., 4(4), 283-294 (2011).

2. 2) Macklis, R. M., Kinsey, B. M., Kassis, A. I., Ferrara, J. L. M., Atcher, R. W., Hines, J. J., Coleman, C. N., Adelstein, S. J., Burakoff, S. J.: Radioimmunotherapy with Alpha-Particle-Emitting Immunoconjugates., Science., 240(4855), 1024-1026 (1988).

3. 3) Uemura, H., Matsubara, N., Kinuya, S., Hosono, M., Yajima, Y., Doi, T.: Safety and Efficacy of Radium-223 Dichloride in Japanese Patients with Castration-Resistant Prostate Cancer and Bone Metastases., Int. J. Clin. Oncol., 22(5), 954-963 (2017).

4. 4) (a) European Medicines Agency. Radium 223 Xofigo (223 Ra dichloride) summary of product characteristics. HP. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002653/WC500156172.pdf (Accessed Apr. 9, 2015).

5. (b) Flux, G. D.: Imaging and dosimetry for radium-223: the potential for personalized treatment., Br. J. Radiol., 90(1077), 748-756 (2017).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?;Frontiers in Medicine;2022-12-22

2. Dispersion of Alpha-Nuclides during Animal Experiments;Radiation Safety Management;2021

3. Preparation of a Guideline for Radiation Safety Management of Short-Lived Radionuclides;RADIOISOTOPES;2020-07-15